Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
The progressive neurological condition affects more than six million people worldwide
Read Moreby Jen Brogan | May 1, 2024 | News | 0
The progressive neurological condition affects more than six million people worldwide
Read Moreby Jen Brogan | Apr 17, 2024 | News | 0
Both companies will facilitate career progression while advancing the life sciences industry
Read Moreby Jen Brogan | Mar 27, 2024 | News | 0
PhaSER will provide 8HUM mouse models for the TDI to accelerate a pipeline of novel therapeutic targets
Read Moreby Jen Brogan | Feb 26, 2024 | News | 0
Every year, tuberculosis, malaria and HIV cause over five million deaths worldwide
Read Moreby Jen Brogan | Jan 3, 2024 | News | 0
The new hub will be located in the King’s Cross Knowledge Quarter, London
Read Moreby Jen Brogan | Nov 29, 2023 | News | 0
The new state-of-the-art facility is set to be operational in early 2024
Read Moreby Jen Brogan | Nov 23, 2023 | News | 0
Both companies will use their platforms to accelerate drug discovery and development
Read Moreby Jen Brogan | Oct 6, 2023 | News | 0
The study used data from 50,000 people in the UK Biobank
Read Moreby Jen Brogan | Sep 12, 2023 | News | 0
The research will aim to reveal the mechanism of action of a drug target candidate
Read Moreby Lucy Parsons | Aug 6, 2021 | News | 0
Acquisition strengthens Bayer’s drug discovery capabilities
Read Moreby Lucy Parsons | Mar 23, 2021 | News | 0
Researchers are aiming to isolate a stable form of the COVID-19 encounter complex
Read Moreby Lucy Parsons | Dec 17, 2020 | News | 0
Consortium is led by Cambridge Medical Research Council (MRC) researchers
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479